Company Description
CVS Health Corporation provides health solutions in the United States.
It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments.
The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.
The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services.
It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans.
The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products.
This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings.
It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services.
The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014.
CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
| Country | United States |
| Founded | 1963 |
| Industry | Healthcare Plans |
| Sector | Healthcare |
| Employees | 300,000 |
| CEO | Ms. Karen Sue Lynch |
Contact Details
Address: One Cvs Dr. Woonsocket, Rhode Island 02895 United States | |
| Phone | (401) 765-1500 |
| Website | cvshealth.com |
Stock Details
| Ticker Symbol | CVS |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000064803 |
| CUSIP Number | 126650100 |
| ISIN Number | US1266501006 |
| Employer ID | 05-0494040 |
| SIC Code | 5912 |
Key Executives
| Name | Position |
|---|---|
| Karen Sue Lynch | President, Chief Executive Officer and Director |
| Thomas Francis Cowhey | Executive Vice President and Chief Financial Officer |
| Tilak Mandadi | Executive Vice President of Ventures and Chief Digital, Data, Analytics and Technology Officer |
| Samrat S. Khichi Esq. | Executive Vice President, Chief Policy Officer and General Counsel |
| Prem S. Shah Pharm.D | Executive Vice President, Chief Pharmacy Officer and President of Pharmacy and Consumer Wellness |
| Vijay Patel | Senior Director of Business Development and CVS Health and Partner & Co-Founder |
| James David Clark | Senior Vice President, Controller and Chief Accounting Officer |
| Laurence F. McGrath | Senior Vice President of Business Development and Investor Relations |
| David A. Falkowski | Executive Vice President and Chief Compliance Officer |
| Laurie P. Havanec | Executive Vice President and Chief People Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 16, 2024 | PX14A6G | Notice of exempt solicitation submitted by non-management |
| Apr 5, 2024 | ARS | Filing |
| Apr 5, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 5, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 5, 2024 | 8-K | Current Report |
| Feb 16, 2024 | 144 | Filing |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 9, 2024 | 13F-HR | Quarterly report filed by institutional managers, holdings |
| Feb 7, 2024 | 10-K | Annual Report |
| Feb 7, 2024 | 8-K | Current Report |